Former Altria Executive Brian Quigley Joins Respira as CEO
Former Altria Group executive Brian Quigley has been appointed as the new CEO of Respira Technologies. Mario Danek, the founder of Respira, will now serve as the Chief Technology Officer.
Respira is a health technology company supported by California venture capital. The company focuses on commercializing medical inhalation device technology to improve patient outcomes. Currently, the company is working with the FDA to achieve joint product authorization and launch the first inhalable prescription smoking cessation therapy.
Quigley spent 16 years working at Altria Group, serving as the President and CEO of the company's smokeless and innovative products/e-cigarette business for 7 years. He has also been an investor in the CBD and alcohol industries, and has served on the board of directors for Mustgrow Biologics and Belle Isle Craft Spirits.
Due to Respira's efforts to secure funding for clinical trials, Danek made significant changes to the company's leadership structure. With a successful business background and experience leading a Fortune 150 company, Quigley's appointment as CEO will help drive Respira into its next phase as it prepares to submit investigational new drug applications and begin human clinical trials. This shift will allow Danek to focus on Respira's technology, specifically inventing and improving its innovative inhalation device for multiple potential indications and target markets.
Statement
This article is compiled from third-party information and is only intended for industry exchange and learning.
This article does not represent the views of 2FIRSTS and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's contents. The translation of this article is only intended for industry-related communication and research.
Due to limitations in the level of translation, the translated version of this article may not fully express the same meaning as the original. Please refer to the original article for accuracy.
In regards to any domestic issues, as well as those concerning Hong Kong, Macau, Taiwan, and foreign affairs, 2FIRSTS maintains complete alignment with the Chinese government.
The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us to have it removed.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
